Sofinnova Partners names industrial biotechnology partner
Street Talk | Episode 98: Regulatory scrutiny having cooling effect on community bank M&A
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Street Talk | Episode 97: Recessionary fears still keeping bank investors on the sidelines
Making sanctions effective: Key themes for banks
Venture capital firm Sofinnova Partners promoted Michael Krel to partner in the industrial biotechnology team.
Krel was previously a principal in the team, focused on early-stage deals in Europe and North America.
France-based Sofinnova Partners specializes in life sciences.